After losing a major ruling in the High Court of Justice in London last year, Pfizer and BioNTech asked the England & Wales Court of Appeal to overturn a decision finding a key Moderna COVID patent was valid and infringed.
Novartis cannot block rival MSN Pharmaceuticals from launching a generic version of its chronic heart failure treatment Entresto before its patent expires in November 2026, the District of Delaware has held.
This message was published Monday, July 14th 2025 at 12:29PM Eastern Standard Time (US)